Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 18 January 1991:
Vol. 251. no. 4991, pp. 305 - 308
DOI: 10.1126/science.1987646
Prev | Table of Contents | Next

Articles

Science, Vol 251, Issue 4991, 305-308
Copyright © 1991 by American Association for the Advancement of Science

articles

The effect of anti-neoplastic drugs on murine acquired immunodeficiency syndrome

C Simard and P Jolicoeur

Laboratory of Molecular Biology, Clinical Research Institute of Montreal, Quebec, Canada.

The murine acquired immunodeficiency syndrome (MAIDS) is associated with proliferation of target cells that have been infected by a defective retrovirus. To control the growth of this primary neoplasia, virus-inoculated mice were treated with anti-neoplastic drugs. Paradoxically, cyclophosphamide, which is also immunosuppressive, was very effective in preventing the appearance and progression of the disease, in restoring a normal T cell function, and in depleting the number of infected target cells. This result suggests that the proliferating infected target cells were responsible for the immunodeficiency.




To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)